Meanwhile, the observed upregulation of neutrophil-related markers (S100A8/A9, MPO) and antigen-presentation machinery (HLA-DRA, ITGAM) reflects an inflamed tumor microenvironment typical of “hot tumors” and supports immune checkpoint inhibitor sensitivity (Zheng et al., 2022). Here, HLA-DRA is linked to neoplasm.